What is LDL Cholesterol?
LDL cholesterol is the amount of cholesterol carried inside low-density lipoprotein (LDL) particles, the main vehicles that move cholesterol from the liver to the rest of the body. On a standard lipid panel it is usually calculated from total cholesterol, HDL, and triglycerides rather than measured directly, and in Europe it is reported in mmol/L (much of the world outside Europe uses mg/dL). Because it is calculated, LDL becomes less reliable when triglycerides are high — and when triglycerides are very high it cannot be calculated accurately at all, so a directly measured LDL or ApoB is used instead. This is one reason LDL is read alongside the rest of the profile rather than on its own. LDL measures the cholesterol cargo, not the number of particles. ApoB counts the atherogenic particles themselves, so the two usually move together but can diverge — most often when triglycerides are raised or particles are small and dense. Where they disagree, ApoB and non-HDL cholesterol tend to track risk more faithfully than LDL alone. LDL is read as part of the whole lipid picture — HDL, triglycerides, total cholesterol, ApoB, and where available Lp(a) — and against your personal baseline and trend, never as a single number in isolation.
Why is LDL Cholesterol relevant?
LDL is a central, causal driver of atherosclerosis — the gradual build-up of cholesterol-rich plaque in the artery wall that underlies most heart attacks and strokes. The relationship is dose- and time-dependent: the more LDL particles circulate and the longer they stay elevated, the more cholesterol is deposited, so cumulative lifetime exposure matters as much as any single reading. This is one of the most robustly established cause-and-effect links in cardiovascular medicine. That causal weight is why lowering LDL is among the best-evidenced of all preventive interventions, through both lifestyle and medication, and why it is a marker worth tracking and acting on early rather than waiting for symptoms — raised LDL itself causes none. As a general, lab-dependent reference (not a diagnosis), an LDL below roughly 3.0 mmol/L (about 115 mg/dL) is often used as a desirable population guide, while preferred targets get lower the higher your cardiovascular risk. In Dutch primary care, the treatment target for people who already have cardiovascular disease (typically up to age 70) is usually under 1.8 mmol/L (about 70 mg/dL), and European specialist guidelines set a still stricter target of under 1.4 mmol/L (about 55 mg/dL) for those at very high risk. The right target is individual — it depends on your overall risk, family history, ApoB, Lp(a), and blood pressure — and is best set with a clinician rather than read off a single threshold.
LDL Cholesterol high or low — what it means
A high LDL means more atherogenic cholesterol is circulating than is ideal for your risk level, but the right target is personal, so read the number against your overall cardiovascular risk rather than one fixed cut-off. Common drivers include a diet high in saturated and trans fats, excess body weight, low physical activity, and an unfavourable metabolic profile — and, importantly, genetics: familial hypercholesterolaemia produces markedly and persistently high LDL from a young age and is worth considering when values are very high or run in the family. Hypothyroidism, some kidney and liver conditions, and certain medications can also raise it. A low LDL is generally favourable for cardiovascular risk, and studies of people with naturally very low lifetime LDL are reassuring. Genuinely low values that were not driven down by treatment are occasionally seen with hyperthyroidism, malnutrition, malabsorption, liver disease, or acute illness, so an unexpectedly low result in someone who is unwell is worth interpreting in context rather than celebrating in isolation. The levers that lower LDL are well established: replacing saturated and trans fats with unsaturated fats, more fibre (especially soluble fibre), more plants, losing excess weight, regular exercise, and not smoking — with a Mediterranean-style pattern a sensible default. Lifestyle typically shifts LDL modestly; where risk is higher or genetics are involved, statins and other lipid-lowering medicines add larger, well-proven reductions, decided with a clinician. LDL is fairly stable but can drift with diet, weight, illness, and thyroid status, so judge the trend across repeat tests rather than one value. Modern panels no longer strictly require fasting, but if triglycerides are measured on the same sample a 9–12 hour fast gives a cleaner result; if you start or change treatment or lifestyle, re-test after a couple of months under comparable conditions, and read LDL together with ApoB and non-HDL.
Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.
Read about our scientific approach →